nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—CYP3A7—Tamoxifen—pancreatic cancer	0.0851	0.102	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0851	0.102	CbGbCtD
Finasteride—CYP3A7—Irinotecan—pancreatic cancer	0.0653	0.0783	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0653	0.0783	CbGbCtD
Finasteride—CYP3A5—Tamoxifen—pancreatic cancer	0.0638	0.0765	CbGbCtD
Finasteride—CYP3A5—Erlotinib—pancreatic cancer	0.0543	0.065	CbGbCtD
Finasteride—CYP3A5—Irinotecan—pancreatic cancer	0.049	0.0587	CbGbCtD
Finasteride—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0479	0.0574	CbGbCtD
Finasteride—CYP3A7—Docetaxel—pancreatic cancer	0.0479	0.0574	CbGbCtD
Finasteride—Breast cancer male—Tamoxifen—pancreatic cancer	0.0478	0.288	CcSEcCtD
Finasteride—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0477	0.0571	CbGbCtD
Finasteride—CYP3A7—Sunitinib—pancreatic cancer	0.0477	0.0571	CbGbCtD
Finasteride—CYP3A5—Docetaxel—pancreatic cancer	0.0359	0.0431	CbGbCtD
Finasteride—CYP3A5—Sunitinib—pancreatic cancer	0.0358	0.0429	CbGbCtD
Finasteride—CYP3A4—Tamoxifen—pancreatic cancer	0.0249	0.0298	CbGbCtD
Finasteride—CYP3A4—Erlotinib—pancreatic cancer	0.0212	0.0254	CbGbCtD
Finasteride—CYP3A4—Irinotecan—pancreatic cancer	0.0191	0.0229	CbGbCtD
Finasteride—CYP3A4—Docetaxel—pancreatic cancer	0.014	0.0168	CbGbCtD
Finasteride—CYP3A4—Sunitinib—pancreatic cancer	0.0139	0.0167	CbGbCtD
Finasteride—CYP3A4—Doxorubicin—pancreatic cancer	0.0104	0.0125	CbGbCtD
Finasteride—Breast cancer—Gemcitabine—pancreatic cancer	0.00431	0.026	CcSEcCtD
Finasteride—Breast cancer—Docetaxel—pancreatic cancer	0.00306	0.0184	CcSEcCtD
Finasteride—Tenderness—Tamoxifen—pancreatic cancer	0.00262	0.0158	CcSEcCtD
Finasteride—Tenderness—Erlotinib—pancreatic cancer	0.00259	0.0156	CcSEcCtD
Finasteride—Neoplasm malignant—Sunitinib—pancreatic cancer	0.00229	0.0138	CcSEcCtD
Finasteride—Neoplasm—Tamoxifen—pancreatic cancer	0.00207	0.0125	CcSEcCtD
Finasteride—Neoplasm malignant—Irinotecan—pancreatic cancer	0.00189	0.0114	CcSEcCtD
Finasteride—Swelling—Tamoxifen—pancreatic cancer	0.00188	0.0113	CcSEcCtD
Finasteride—Neoplasm malignant—Gemcitabine—pancreatic cancer	0.00184	0.0111	CcSEcCtD
Finasteride—Injury—Tamoxifen—pancreatic cancer	0.00181	0.0109	CcSEcCtD
Finasteride—Tenderness—Gemcitabine—pancreatic cancer	0.0018	0.0109	CcSEcCtD
Finasteride—Tenderness—Fluorouracil—pancreatic cancer	0.00177	0.0107	CcSEcCtD
Finasteride—Neoplasm—Sunitinib—pancreatic cancer	0.00177	0.0107	CcSEcCtD
Finasteride—Prostatic disorder—Epirubicin—pancreatic cancer	0.00177	0.0107	CcSEcCtD
Finasteride—Prostatic disorder—Doxorubicin—pancreatic cancer	0.00164	0.00987	CcSEcCtD
Finasteride—Neoplasm—Irinotecan—pancreatic cancer	0.00146	0.0088	CcSEcCtD
Finasteride—Influenza—Tamoxifen—pancreatic cancer	0.00143	0.00865	CcSEcCtD
Finasteride—Bronchitis—Tamoxifen—pancreatic cancer	0.00138	0.00832	CcSEcCtD
Finasteride—Erectile dysfunction—Tamoxifen—pancreatic cancer	0.00132	0.00797	CcSEcCtD
Finasteride—Injury—Irinotecan—pancreatic cancer	0.00127	0.00768	CcSEcCtD
Finasteride—Swelling—Fluorouracil—pancreatic cancer	0.00127	0.00767	CcSEcCtD
Finasteride—Sinusitis—Tamoxifen—pancreatic cancer	0.0012	0.00724	CcSEcCtD
Finasteride—Bronchitis—Sunitinib—pancreatic cancer	0.00118	0.00713	CcSEcCtD
Finasteride—Pharyngitis—Tamoxifen—pancreatic cancer	0.00114	0.00687	CcSEcCtD
Finasteride—Oedema peripheral—Tamoxifen—pancreatic cancer	0.00113	0.00682	CcSEcCtD
Finasteride—Orthostatic hypotension—Irinotecan—pancreatic cancer	0.00107	0.00645	CcSEcCtD
Finasteride—Neoplasm—Docetaxel—pancreatic cancer	0.00101	0.00608	CcSEcCtD
Finasteride—Mental disorder—Erlotinib—pancreatic cancer	0.000995	0.006	CcSEcCtD
Finasteride—Influenza—Gemcitabine—pancreatic cancer	0.000986	0.00595	CcSEcCtD
Finasteride—Oedema peripheral—Sunitinib—pancreatic cancer	0.000969	0.00584	CcSEcCtD
Finasteride—Swelling—Docetaxel—pancreatic cancer	0.000917	0.00553	CcSEcCtD
Finasteride—Angioedema—Tamoxifen—pancreatic cancer	0.000913	0.00551	CcSEcCtD
Finasteride—Immune system disorder—Sunitinib—pancreatic cancer	0.000888	0.00536	CcSEcCtD
Finasteride—Neoplasm malignant—Epirubicin—pancreatic cancer	0.000881	0.00531	CcSEcCtD
Finasteride—Mental disorder—Sunitinib—pancreatic cancer	0.000861	0.0052	CcSEcCtD
Finasteride—Neoplasm malignant—Doxorubicin—pancreatic cancer	0.000815	0.00492	CcSEcCtD
Finasteride—Rhinitis—Irinotecan—pancreatic cancer	0.000812	0.0049	CcSEcCtD
Finasteride—Sinusitis—Fluorouracil—pancreatic cancer	0.000811	0.00489	CcSEcCtD
Finasteride—Infection—Tamoxifen—pancreatic cancer	0.00081	0.00489	CcSEcCtD
Finasteride—Infection—Erlotinib—pancreatic cancer	0.000802	0.00484	CcSEcCtD
Finasteride—Rhinitis—Gemcitabine—pancreatic cancer	0.000791	0.00477	CcSEcCtD
Finasteride—Pharyngitis—Gemcitabine—pancreatic cancer	0.000783	0.00472	CcSEcCtD
Finasteride—Angioedema—Sunitinib—pancreatic cancer	0.000782	0.00472	CcSEcCtD
Finasteride—Rhinitis—Fluorouracil—pancreatic cancer	0.000778	0.00469	CcSEcCtD
Finasteride—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000777	0.00469	CcSEcCtD
Finasteride—Pharyngitis—Fluorouracil—pancreatic cancer	0.00077	0.00464	CcSEcCtD
Finasteride—Orthostatic hypotension—Docetaxel—pancreatic cancer	0.000739	0.00446	CcSEcCtD
Finasteride—Immune system disorder—Irinotecan—pancreatic cancer	0.000732	0.00441	CcSEcCtD
Finasteride—Breast disorder—Docetaxel—pancreatic cancer	0.000731	0.00441	CcSEcCtD
Finasteride—Dyspnoea—Tamoxifen—pancreatic cancer	0.000727	0.00439	CcSEcCtD
Finasteride—Dyspnoea—Erlotinib—pancreatic cancer	0.000719	0.00434	CcSEcCtD
Finasteride—Immune system disorder—Gemcitabine—pancreatic cancer	0.000713	0.0043	CcSEcCtD
Finasteride—Pain—Tamoxifen—pancreatic cancer	0.000698	0.00421	CcSEcCtD
Finasteride—Infection—Sunitinib—pancreatic cancer	0.000694	0.00419	CcSEcCtD
Finasteride—Pain—Erlotinib—pancreatic cancer	0.00069	0.00416	CcSEcCtD
Finasteride—Neoplasm—Epirubicin—pancreatic cancer	0.00068	0.0041	CcSEcCtD
Finasteride—Urticaria—Tamoxifen—pancreatic cancer	0.000648	0.00391	CcSEcCtD
Finasteride—Neoplasm—Doxorubicin—pancreatic cancer	0.000629	0.0038	CcSEcCtD
Finasteride—Dyspnoea—Sunitinib—pancreatic cancer	0.000623	0.00376	CcSEcCtD
Finasteride—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000601	0.00363	CcSEcCtD
Finasteride—Pain—Sunitinib—pancreatic cancer	0.000597	0.0036	CcSEcCtD
Finasteride—Asthenia—Tamoxifen—pancreatic cancer	0.000585	0.00353	CcSEcCtD
Finasteride—Asthenia—Erlotinib—pancreatic cancer	0.000579	0.00349	CcSEcCtD
Finasteride—Pruritus—Tamoxifen—pancreatic cancer	0.000577	0.00348	CcSEcCtD
Finasteride—Infection—Irinotecan—pancreatic cancer	0.000572	0.00345	CcSEcCtD
Finasteride—Pruritus—Erlotinib—pancreatic cancer	0.000571	0.00344	CcSEcCtD
Finasteride—Rhinitis—Docetaxel—pancreatic cancer	0.000561	0.00339	CcSEcCtD
Finasteride—Infection—Gemcitabine—pancreatic cancer	0.000557	0.00336	CcSEcCtD
Finasteride—Pharyngitis—Docetaxel—pancreatic cancer	0.000556	0.00335	CcSEcCtD
Finasteride—Oedema peripheral—Docetaxel—pancreatic cancer	0.000552	0.00333	CcSEcCtD
Finasteride—Infection—Fluorouracil—pancreatic cancer	0.000548	0.0033	CcSEcCtD
Finasteride—Dizziness—Tamoxifen—pancreatic cancer	0.000539	0.00325	CcSEcCtD
Finasteride—Hypotension—Irinotecan—pancreatic cancer	0.000538	0.00324	CcSEcCtD
Finasteride—Dizziness—Erlotinib—pancreatic cancer	0.000534	0.00322	CcSEcCtD
Finasteride—Hypotension—Gemcitabine—pancreatic cancer	0.000524	0.00316	CcSEcCtD
Finasteride—Hypotension—Fluorouracil—pancreatic cancer	0.000515	0.00311	CcSEcCtD
Finasteride—Hypersensitivity—Sunitinib—pancreatic cancer	0.000515	0.0031	CcSEcCtD
Finasteride—Rash—Tamoxifen—pancreatic cancer	0.000514	0.0031	CcSEcCtD
Finasteride—Dermatitis—Tamoxifen—pancreatic cancer	0.000514	0.0031	CcSEcCtD
Finasteride—Dyspnoea—Irinotecan—pancreatic cancer	0.000513	0.00309	CcSEcCtD
Finasteride—Somnolence—Irinotecan—pancreatic cancer	0.000512	0.00309	CcSEcCtD
Finasteride—Headache—Tamoxifen—pancreatic cancer	0.000511	0.00308	CcSEcCtD
Finasteride—Rash—Erlotinib—pancreatic cancer	0.000509	0.00307	CcSEcCtD
Finasteride—Dermatitis—Erlotinib—pancreatic cancer	0.000508	0.00307	CcSEcCtD
Finasteride—Immune system disorder—Docetaxel—pancreatic cancer	0.000506	0.00305	CcSEcCtD
Finasteride—Headache—Erlotinib—pancreatic cancer	0.000506	0.00305	CcSEcCtD
Finasteride—Asthenia—Sunitinib—pancreatic cancer	0.000501	0.00302	CcSEcCtD
Finasteride—Dyspnoea—Gemcitabine—pancreatic cancer	0.0005	0.00301	CcSEcCtD
Finasteride—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000499	0.00301	CcSEcCtD
Finasteride—Somnolence—Gemcitabine—pancreatic cancer	0.000498	0.00301	CcSEcCtD
Finasteride—Pruritus—Sunitinib—pancreatic cancer	0.000494	0.00298	CcSEcCtD
Finasteride—Breast disorder—Epirubicin—pancreatic cancer	0.000493	0.00298	CcSEcCtD
Finasteride—Pain—Irinotecan—pancreatic cancer	0.000492	0.00297	CcSEcCtD
Finasteride—Dyspnoea—Fluorouracil—pancreatic cancer	0.000491	0.00296	CcSEcCtD
Finasteride—Mental disorder—Docetaxel—pancreatic cancer	0.000491	0.00296	CcSEcCtD
Finasteride—Somnolence—Fluorouracil—pancreatic cancer	0.00049	0.00296	CcSEcCtD
Finasteride—Pain—Gemcitabine—pancreatic cancer	0.000479	0.00289	CcSEcCtD
Finasteride—Influenza—Epirubicin—pancreatic cancer	0.000472	0.00285	CcSEcCtD
Finasteride—Pain—Fluorouracil—pancreatic cancer	0.000471	0.00284	CcSEcCtD
Finasteride—Dizziness—Sunitinib—pancreatic cancer	0.000462	0.00279	CcSEcCtD
Finasteride—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000461	0.00278	CcSEcCtD
Finasteride—Breast disorder—Doxorubicin—pancreatic cancer	0.000456	0.00275	CcSEcCtD
Finasteride—Bronchitis—Epirubicin—pancreatic cancer	0.000454	0.00274	CcSEcCtD
Finasteride—Rash—Sunitinib—pancreatic cancer	0.00044	0.00266	CcSEcCtD
Finasteride—Dermatitis—Sunitinib—pancreatic cancer	0.00044	0.00265	CcSEcCtD
Finasteride—Urticaria—Fluorouracil—pancreatic cancer	0.000438	0.00264	CcSEcCtD
Finasteride—Headache—Sunitinib—pancreatic cancer	0.000438	0.00264	CcSEcCtD
Finasteride—Influenza—Doxorubicin—pancreatic cancer	0.000437	0.00263	CcSEcCtD
Finasteride—Hypersensitivity—Irinotecan—pancreatic cancer	0.000424	0.00256	CcSEcCtD
Finasteride—Bronchitis—Doxorubicin—pancreatic cancer	0.00042	0.00253	CcSEcCtD
Finasteride—Asthenia—Irinotecan—pancreatic cancer	0.000413	0.00249	CcSEcCtD
Finasteride—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000406	0.00245	CcSEcCtD
Finasteride—Asthenia—Gemcitabine—pancreatic cancer	0.000402	0.00243	CcSEcCtD
Finasteride—Pruritus—Gemcitabine—pancreatic cancer	0.000397	0.00239	CcSEcCtD
Finasteride—Infection—Docetaxel—pancreatic cancer	0.000395	0.00238	CcSEcCtD
Finasteride—Sinusitis—Epirubicin—pancreatic cancer	0.000395	0.00238	CcSEcCtD
Finasteride—Pruritus—Fluorouracil—pancreatic cancer	0.00039	0.00235	CcSEcCtD
Finasteride—Dizziness—Irinotecan—pancreatic cancer	0.000381	0.0023	CcSEcCtD
Finasteride—Rhinitis—Epirubicin—pancreatic cancer	0.000379	0.00228	CcSEcCtD
Finasteride—Pharyngitis—Epirubicin—pancreatic cancer	0.000375	0.00226	CcSEcCtD
Finasteride—Oedema peripheral—Epirubicin—pancreatic cancer	0.000372	0.00224	CcSEcCtD
Finasteride—Hypotension—Docetaxel—pancreatic cancer	0.000372	0.00224	CcSEcCtD
Finasteride—Sinusitis—Doxorubicin—pancreatic cancer	0.000365	0.0022	CcSEcCtD
Finasteride—Dizziness—Fluorouracil—pancreatic cancer	0.000364	0.0022	CcSEcCtD
Finasteride—Rash—Irinotecan—pancreatic cancer	0.000363	0.00219	CcSEcCtD
Finasteride—Dermatitis—Irinotecan—pancreatic cancer	0.000362	0.00219	CcSEcCtD
Finasteride—Headache—Irinotecan—pancreatic cancer	0.000361	0.00217	CcSEcCtD
Finasteride—Dyspnoea—Docetaxel—pancreatic cancer	0.000355	0.00214	CcSEcCtD
Finasteride—Somnolence—Docetaxel—pancreatic cancer	0.000354	0.00213	CcSEcCtD
Finasteride—Rash—Gemcitabine—pancreatic cancer	0.000353	0.00213	CcSEcCtD
Finasteride—Dermatitis—Gemcitabine—pancreatic cancer	0.000353	0.00213	CcSEcCtD
Finasteride—Headache—Gemcitabine—pancreatic cancer	0.000351	0.00212	CcSEcCtD
Finasteride—Rhinitis—Doxorubicin—pancreatic cancer	0.00035	0.00211	CcSEcCtD
Finasteride—Rash—Fluorouracil—pancreatic cancer	0.000348	0.0021	CcSEcCtD
Finasteride—Dermatitis—Fluorouracil—pancreatic cancer	0.000347	0.00209	CcSEcCtD
Finasteride—Pharyngitis—Doxorubicin—pancreatic cancer	0.000347	0.00209	CcSEcCtD
Finasteride—Headache—Fluorouracil—pancreatic cancer	0.000345	0.00208	CcSEcCtD
Finasteride—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000344	0.00208	CcSEcCtD
Finasteride—Immune system disorder—Epirubicin—pancreatic cancer	0.000341	0.00206	CcSEcCtD
Finasteride—Pain—Docetaxel—pancreatic cancer	0.00034	0.00205	CcSEcCtD
Finasteride—Mental disorder—Epirubicin—pancreatic cancer	0.000331	0.002	CcSEcCtD
Finasteride—Immune system disorder—Doxorubicin—pancreatic cancer	0.000316	0.0019	CcSEcCtD
Finasteride—Mental disorder—Doxorubicin—pancreatic cancer	0.000306	0.00185	CcSEcCtD
Finasteride—Hypersensitivity—Docetaxel—pancreatic cancer	0.000293	0.00177	CcSEcCtD
Finasteride—Asthenia—Docetaxel—pancreatic cancer	0.000285	0.00172	CcSEcCtD
Finasteride—Pruritus—Docetaxel—pancreatic cancer	0.000281	0.0017	CcSEcCtD
Finasteride—Infection—Epirubicin—pancreatic cancer	0.000267	0.00161	CcSEcCtD
Finasteride—Dizziness—Docetaxel—pancreatic cancer	0.000263	0.00159	CcSEcCtD
Finasteride—Rash—Docetaxel—pancreatic cancer	0.000251	0.00151	CcSEcCtD
Finasteride—Hypotension—Epirubicin—pancreatic cancer	0.000251	0.00151	CcSEcCtD
Finasteride—Dermatitis—Docetaxel—pancreatic cancer	0.000251	0.00151	CcSEcCtD
Finasteride—Headache—Docetaxel—pancreatic cancer	0.000249	0.0015	CcSEcCtD
Finasteride—Infection—Doxorubicin—pancreatic cancer	0.000247	0.00149	CcSEcCtD
Finasteride—Dyspnoea—Epirubicin—pancreatic cancer	0.000239	0.00144	CcSEcCtD
Finasteride—Somnolence—Epirubicin—pancreatic cancer	0.000239	0.00144	CcSEcCtD
Finasteride—Hypotension—Doxorubicin—pancreatic cancer	0.000232	0.0014	CcSEcCtD
Finasteride—Pain—Epirubicin—pancreatic cancer	0.000229	0.00138	CcSEcCtD
Finasteride—Dyspnoea—Doxorubicin—pancreatic cancer	0.000221	0.00134	CcSEcCtD
Finasteride—Somnolence—Doxorubicin—pancreatic cancer	0.000221	0.00133	CcSEcCtD
Finasteride—Urticaria—Epirubicin—pancreatic cancer	0.000213	0.00129	CcSEcCtD
Finasteride—Pain—Doxorubicin—pancreatic cancer	0.000212	0.00128	CcSEcCtD
Finasteride—Hypersensitivity—Epirubicin—pancreatic cancer	0.000198	0.00119	CcSEcCtD
Finasteride—Urticaria—Doxorubicin—pancreatic cancer	0.000197	0.00119	CcSEcCtD
Finasteride—Asthenia—Epirubicin—pancreatic cancer	0.000193	0.00116	CcSEcCtD
Finasteride—Pruritus—Epirubicin—pancreatic cancer	0.00019	0.00115	CcSEcCtD
Finasteride—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000183	0.0011	CcSEcCtD
Finasteride—Asthenia—Doxorubicin—pancreatic cancer	0.000178	0.00107	CcSEcCtD
Finasteride—Dizziness—Epirubicin—pancreatic cancer	0.000177	0.00107	CcSEcCtD
Finasteride—Pruritus—Doxorubicin—pancreatic cancer	0.000176	0.00106	CcSEcCtD
Finasteride—Rash—Epirubicin—pancreatic cancer	0.000169	0.00102	CcSEcCtD
Finasteride—Dermatitis—Epirubicin—pancreatic cancer	0.000169	0.00102	CcSEcCtD
Finasteride—Headache—Epirubicin—pancreatic cancer	0.000168	0.00101	CcSEcCtD
Finasteride—Dizziness—Doxorubicin—pancreatic cancer	0.000164	0.00099	CcSEcCtD
Finasteride—Rash—Doxorubicin—pancreatic cancer	0.000157	0.000944	CcSEcCtD
Finasteride—Dermatitis—Doxorubicin—pancreatic cancer	0.000156	0.000943	CcSEcCtD
Finasteride—Headache—Doxorubicin—pancreatic cancer	0.000156	0.000938	CcSEcCtD
